Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II - Sensitization in human adrenocortical cells

International Journal of Obesity

Volumn 31, Issue 10, 2007, Pages 1605-1616

  Krug, A W ^a   Vleugels, K ^a   Schinner, S ^b   Lamounier Zepter, V ^a   Ziegler, C G ^a   Bornstein, S R ^a   Ehrhart Bornstein, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adrenal glands; Aldosterone; Extracellular regulated kinases; Fat cell; Hypertension

Indexed keywords

ADIPOCYTOKINE; ALDOSTERONE; ANGIOTENSIN II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ADIPOCYTE; ADRENAL CORTEX CELL; ADULT; ALDOSTERONE RELEASE; ARTICLE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INTRACELLULAR TRANSPORT; NORMAL HUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REPORTER GENE; SCREENING; SENSITIZATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; SUBCUTANEOUS FAT; TIME; UPREGULATION; WESTERN BLOTTING;

ADIPOCYTES; ADIPOKINES; ADRENAL CORTEX; ADULT; ALDOSTERONE; ANGIOTENSIN II; CELL LINE; FEMALE; HUMANS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEINS; UP-REGULATION; VASOCONSTRICTOR AGENTS;

EID: 34748864760     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803642     Document Type: Article

References (47)

1. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
2. Lamounier-Zepter V, Bornstein SR, Ehrhart-Bornstein M. Mechanisms of obesity-related hypertension. Horm Metab Res 2004; 36: 376-380.
3. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633.
4. Schram MT, Stehouwer CD. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005; 37S1: 49-55.
5. Goodfriend TL, Egan BM, Kelley DE. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 401-405.
6. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362.
7. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens 1994; 7: 886-893.
8. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 1994; 7: 314-320.
9. Messerli FH, Christie B, DeCarvalho JG, Aristimuno GG, Suarez DH, Dreslinski GR et al. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med 1981; 141: 81-85.
10. Goodfriend TL. Aldosterone - a hormone of cardiovascular adaptation and maladaptation. J Clin Hypertens (Greenwich) 2006; 8: 133-139.
11. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res 1998; 24: 789-796.
12. El Gharbawy AH, Nadig VS, Kotchen JM, Grim CE, Sagar KB, Kaldunski M et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension 2001; 37: 845-850.
13. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
14. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.
15. Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 2005; 186: 1-20.
16. Epstein M. Aldosterone as a determinant of cardiovascular and renal dysfunction. J R Soc Med 2001; 94: 378-383.
17. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998; 19: 101-143.
18. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A et al. Human adipocytes secrete mineralocorticoid releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211-14216.
19. Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WA, Bornstein SR. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 2004; 30: 865-870.
20. Otis M, Campbell S, Payet MD, Gallo-Payet N. Angiotensin II stimulates protein synthesis and inhibits proliferation in primary cultures of rat adrenal glomerulosa cells. Endocrinology 2005; 146: 633-642.
21. Shah BH, Baukal AJ, Shah FB, Catt KJ. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Mol Endocrinol 2005; 19: 2535-2548.
22. Glasow A, Breidert M, Haidan A, Anderegg U, Kelly PA, Bornstein SR. Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab 1996; 81: 3103-3111.
23. Krug AW, Schuster C, Gassner B, Freudinger R, Mildenberger S, Troppmair J et al. Human epidermal growth factor receptor-1 expression renders Chinese hamster ovary cells sensitive to alternative aldosterone signaling. J Biol Chem 2002; 277: 45892-45897.
24. Krug AW, Grossmann C, Schuster C, Freudinger R, Mildenberger S, Govindan MV et al. Aldosterone stimulates epidermal growth factor receptor expression. J Biol Chem 2003; 278: 43060-43066.
25. Rochford JJ, Semple RK, Laudes M, Boyle KB, Christodoulides C, Mulligan C et al. ETO/MTG8 is an inhibitor of C/EBPbeta activity and a regulator of early adipogenesis. Mol Cell Biol 2004; 24: 9863-9872.
26. Rainey WE, Bird IM, Mason JI. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 1994; 100: 45-50.
27. Lin D, Sugawara T, Strauss III JF, Clark BJ, Stocco DM, Saenger P et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267: 1828-1831.
28. Stocco DM. Steroidogenic acute regulatory protein. Vitam Horm 1999; 55: 399-441.
29. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996; 17: 221-244.
30. Stocco DM, Wang X, Jo Y, Manna PR. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol Endocrinol 2005; 19: 2647-2659.
31. Le Roy C, Li JY, Stocco DM, Langlois D, Saez JM. Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growth factor-beta, and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P450c17, and 3beta-hydroxysteroid dehydrogenase. Endocrinology 2000; 141: 1599-1607.
32. Fleury A, Mathieu AP, Ducharme L, Hales DB, Lehoux JG. Phosphorylation and function of the hamster adrenal steroidogenic acute regulatory protein (StAR). J Steroid Biochem Mol Biol 2004; 91: 259-271.
33. Reinhart AJ, Williams SC, Stocco DM. Transcriptional regulation of the StAR gene. Mol Cell Endocrinol 1999; 151: 161-169.
34. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss III JF et al. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 2001; 276: 13957-13964.
35. Martinelle N, Holst M, Soder O, Svechnikov K. Extracellular signal-regulated kinases are involved in the acute activation of steroidogenesis in immature rat Leydig cells by human chorionic gonadotropin. Endocrinology 2004; 145: 4629-4634.
36. Cameron MR, Foster JS, Bukovsky A, Wimalasena J. Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5′-monophosphates in porcine granulosa cells. Biol Reprod 1996; 55: 111-119.
37. Das S, Maizels ET, DeManno D, St Clair E, Adam SA, Hunzicker-Dunn M. A stimulatory role of cyclic adenosine 3′,5′-monophosphate in follicle-stimulating hormone-activated mitogen-activated protein kinase signaling pathway in rat ovarian granulosa cells. Endocrinology 1996; 137: 967-974.
38. Tian Y, Smith RD, Balla T, Catt KJ. Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. Endocrinology 1998; 139: 1801-1809.
39. Watanabe G, Lee RJ, Albanese C, Rainey WE, Batlle D, Pestell RG. Angiotensin II activation of cyclin D1-dependent kinase activity. J Biol Chem 1996; 271: 22570-22577.
40. Natarajan R, Yang DC, Lanting L, Nadler JL. Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells. Endocrine 2002; 18: 295-301.
41. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T, Makino H. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 2004; 145: 639-649.
42. Manna PR, Chandrala SP, Jo Y, Stocco DM. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation. J Mol Endocrinol 2006; 37: 81-95.
43. Lin T, Wang D, Hu J, Stocco DM. Upregulation of human chorionic gonadotrophin-induced steroidogenic acute regulatory protein by insulin-like growth factor-I in rat Leydig cells. Endocrine 1998; 8: 73-78.
44. Manna PR, Huhtaniemi IT, Wang XJ, Eubank DW, Stocco DM. Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells. Biol Reprod 2002; 67: 1393-1404.
45. Saez JM. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev 1994; 15: 574-626.
46. Krug AW, Ehrhart-Bornstein M. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cell Mol Life Sci 2005; 62: 1359-1362.
47. Lamounier-Zepter V, Rotthoff T, Ansurudeen I, Kopprasch S, Scherbaum WA, Ehrhart-Bornstein M et al. Increased aldosterone/ renin quotient in obese hypertensive women. Possible role of LDL. Horm Metab Res 2006; 38: 471-475.